International Society for Pharmaceutical Engineering launches prevention plan to tackle drug shortages

3 October 2014
ispe-big

The International Society for Pharmaceutical Engineering (ISPE) is to release its Drug Shortages Prevention Plan at its annual meeting in Las Vegas.

The ISPE Drug Shortages Task Team developed the plan as part of its initiative launched in response to a European Medicines Agency request for a collaborative action plan developed to stop drug shortages due to manufacturing and quality issues.

The ISPE’s plan lays out how the industry can effectively prevent drug shortages from occurring by identifying the causes of supply disruptions and creating a culture of quality that ensures robust, resilient and reliable medication supply.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical